Valion Bio Advances U.S. Department Of War And BARDA Engagement On Entolimod Radiation Countermeasure; Highlights Interest In Oral Formulation For Field Deployment And National Stockpiles
Valion Bio Inc VBIO
$0.88
▲ +0.80%
(+$0.01)
Open
$0.85
Prev Close
$0.87
Day Range
$0.81 – $0.88
52W Range
$0.80 – $1.21
Market Cap
$2.60M
Beta
3.46
EPS (TTM)
$-9.87
📋 Company Profile
| Industry | Health Care |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 2021-11-11 |
| Shares Out. | 3,200,000 |
| Website | tivichealth.com ↗ |
| Phone | 3026365401 |
Valion Bio Inc is a publicly traded company under the ticker symbol VBIO on the NASDAQ NMS - GLOBAL MARKET, operating in the Health Care industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📰 Latest News for VBIO
Valion Bio's Velocity Bioworks Secures Exclusive Commercial License to LarmorBio's BioScan-NMR Platform
Valion Bio Inc. (VBIO) Q1 2026 Earnings Call Prepared Remarks Transcript
Transcript : Valion Bio, Inc., Q1 2026 Earnings Call, May 14, 2026
Valion Bio Q1 2026 Earnings Call: Complete Transcript
Valion Bio reports first quarter 2026 financial results
Valion Bio : Velocity Bioworks Secures Exclusive Commercial License to LarmorBio's BioScan-NMR™ Platform
Valion Bio's Velocity Bioworks Enters Into Exclusive Commercial Development And License Agreement With LarmorBio For BioScan-NMR Platform